The estimated Net Worth of Robert J Palmisano is at least $33.9 Milión dollars as of 26 November 2019. Mr. Palmisano owns over 145,000 units of Wright Medical NV stock worth over $26,612,197 and over the last 9 years he sold WMGI stock worth over $0. In addition, he makes $7,309,180 as President and Chief Executive Officer a Executive Director at Wright Medical NV.
Sign up
Mr. Palmisano WMGI stock SEC Form 4 insiders trading
Robert has made over 2 trades of the Wright Medical NV stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 145,000 units of WMGI stock worth $2,254,750 on 26 November 2019.
The largest trade he's ever made was exercising 145,000 units of Wright Medical NV stock on 26 November 2019 worth over $2,254,750. On average, Robert trades about 12,777 units every 7 days since 2015. As of 26 November 2019 he still owns at least 887,665 units of Wright Medical NV stock.
You can see the complete history of Mr. Palmisano stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Robert Palmisano biography
Robert J. Palmisano serves as President and Chief Executive Officer, Executive Director of the Company. Mr. Palmisano has served as President and Chief Executive Officer of Wright Medical Group, Inc. since September 2011. Prior to joining legacy Wright, Mr. Palmisano served as President and Chief Executive Officer of ev3 Inc., a global endovascular device company, from April 2008 to July 2010, when it was acquired by Covidien plc. From 2003 to 2007, Mr. Palmisano was President and Chief Executive Officer of IntraLase Corp. Before joining IntraLase, Mr. Palmisano was President and Chief Executive Officer of MacroChem Corporation from 2001 to 2003. Mr. Palmisano previously served on the board of directors of Avedro, Inc., ev3 Inc., Osteotech, Inc. and Abbott Medical Optics, Inc., all publicly held companies, and Bausch & Lomb, a privately held company. Under the terms of his employment agreement, we have agreed that Mr. Palmisano will be nominated by our board of directors for election as executive director and a member of our board of directors at each annual general meeting of shareholders during the term of his employment as President and Chief Executive Officer of Wright. Mr. Palmisano’s qualifications to serve on our board of directors include his day-to-day knowledge of Wright and its business due to his position as President and Chief Executive Officer, his experience serving on other public companies’ boards of directors, and his extensive business knowledge working with other public companies in the medical device industry..
What is the salary of Robert Palmisano?
As the President and Chief Executive Officer a Executive Director of Wright Medical NV, the total compensation of Robert Palmisano at Wright Medical NV is $7,309,180. There are no executives at Wright Medical NV getting paid more.
How old is Robert Palmisano?
Robert Palmisano is 75, he's been the President and Chief Executive Officer a Executive Director of Wright Medical NV since 2015. There are no older and 23 younger executives at Wright Medical NV.
What's Robert Palmisano's mailing address?
Robert's mailing address filed with the SEC is 1023, Cherry Road, The Village, Memphis, Shelby County, Tennessee, 38117, United States of America.
Insiders trading at Wright Medical NV
Over the last 9 years, insiders at Wright Medical NV have traded over $526,674,381 worth of Wright Medical NV stock and bought 118,654 units worth $2,654,459 . The most active insiders traders include Sean Carney, Elizabeth H Weatherman a Holdings Cooperatief U.A.Wa.... On average, Wright Medical NV executives and independent directors trade stock every 9 days with the average trade being worth of $4,402,563. The most recent stock trade was executed by Tim Lanier on 17 August 2020, trading 951 units of WMGI stock currently worth $28,644.
What does Wright Medical NV do?
Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.
What does Wright Medical NV's logo look like?
Complete history of Mr. Palmisano stock trades at Wright Medical NV
Wright Medical NV executives and stock owners
Wright Medical NV executives and other stock owners filed with the SEC include:
-
Robert Palmisano,
President and Chief Executive Officer, Executive Director -
Peter Cooke,
President, Emerging Markets, Australia and Japan -
Lance Berry,
Executive Vice President, Chief Financial and Operations Officer -
Kevin Cordell,
Executive Vice President, Chief Global Commercial Officer -
Andrew Morton,
Senior Vice President, Chief Human Resources Officer -
James Lightman,
Senior Vice President, General Counsel and Secretary -
Barry Regan,
Senior Vice President, Operations -
Jason Asper,
Senior Vice President, Chief Digital Officer -
David Stevens,
Non-Executive Independent Chairman of the Board -
Kevin O'Boyle,
Non-Executive Independent Director -
Elizabeth Weatherman,
Non-Executive Independent Director -
John Miclot,
Non-Executive Independent Director -
Richard Wallman,
Non-Executive Independent Director -
Gary Blackford,
Non-Executive Independent Director -
Amy Paul,
Non-Executive Independent Director -
James Mackin,
Non-Executive Independent Director -
Steven Wallace,
President, International -
Kevin Smith,
Senior Vice President, Quality and Regulatory -
Julie Dewey,
Senior Vice President, Chief Communications Officer -
Timothy Lanier,
President, Upper Extremities -
Patrick Fisher,
President, Lower Extremities -
Julie Andrews,
Senior Vice President, Global Finance -
Jennifer Walker,
Senior Vice President, Process Improvement -
J. Porter,
Senior Vice President, Chief Compliance Officer -
Tim Lanier,
President, Upper Extremities -
Sean Carney,
Director -
William L. Jr Griffin,
SVP GM BioMimetic Therapeutics -
Terry M. Rich,
President, Upper Extremities -
Gregory Morrison,
Sr. VP, Human Resources -
Robert P. Iii Burrows,
SVP, Supply Chain -
David H Mowry,
EVP and COO -
Ummersen Gordon Van,
Sr. VP, Product Delivery -
Holdings Cooperatief U.A.Wa...,
-
Alain Tornier,
Director -
Richard B Emmitt,
Director -
Kevin M Klemz,
Sr. VP, CLO and Secretary -
Shawn Mc Cormick,
Chief Financial Officer -
Medical Group N.V. Wright,
President, Lower Extremities